Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
180.7 BRL | -4.29% | -.--% | -0.10% |
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.10% | 8.43B | - | ||
-4.65% | 1.38B | D | ||
-13.34% | 1.28B | B+ | ||
-5.79% | 1.2B | - | ||
-26.51% | 770M | - | - | |
-.--% | 617M | - | - | |
+3.68% | 466M | - | ||
+2.04% | 433M | - | - | |
-31.93% | 301M | - | - | |
-62.49% | 269M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HSIC Stock
- H1SI34 Stock
- Ratings Henry Schein, Inc.